Abstract:Rationale: Regulatory processes of transcription factors (TFs) shape heart development and influence the adult heart's response to stress, contributing to cardiac disorders. Despite their significance, the precise mechanisms underpinning TF-mediated regulation remain elusive. Here, we identify that EBF1, as a TF, is highly expressed in human heart tissues. EBF1 is reported to be associated with human cardiovascular disease, but its roles are unclear in heart. In this study, we investigated EBF1 function in cardiac system. Methods: RNA-seq was utilized to profile EBF1 expression patterns. CRISPR/Cas9 was utilized to knock out EBF1 to investigate its effects. Human pluripotent stem cells (hPSCs) differentiated into cardiac lineages were used to mimic cardiac development. Cardiac function was evaluated on mouse model with Ebf1 knockout by using techniques such as echocardiography. RNA-seq was conducted to analyze transcriptional perturbations. ChIP-seq was employed to elucidate EBF1-bound genes and the underlying regulatory mechanisms. Results: EBF1 was expressed in some human and mouse cardiomyocyte. Knockout of EBF1 inhibited cardiac development. ChIP-seq indicated EBF1's binding on promoters of cardiogenic TFs pivotal to cardiac development, facilitating their transcriptional expression and promoting cardiac development. In mouse, Ebf1 depletion triggered transcriptional perturbations of genes, resulting in cardiac remodeling. Mechanistically, we found that EBF1 directly bound to upstream chromatin regions of cardiac hypertrophy-inducing genes, contributing to cardiac hypertrophy. Conclusions: We uncover the mechanisms underlying EBF1-mediated regulatory processes, shedding light on cardiac development, and the pathogenesis of cardiac remodeling. These findings emphasize EBF1's critical role in orchestrating diverse aspects of cardiac processes and provide a promising therapeutic intervention for cardiomyopathy.

Tbx20 functions as an important regulator of estrogen-mediated cardiomyocyte protection during oxidative stress

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.

The Protective Role of Bfgf in Myocardial Infarction and Hypoxia Cardiomyocytes by Reducing Oxidative Stress Via Nrf2

Contribution of Increased Expression of Yin Yang 2 to Development of Cardiomyopathy.

ER stress induces upregulation of transcription factor Tbx20 and downstream Bmp2 signaling to promote cardiomyocyte survival

Cuedc2 Modulates Cardiomyocyte Oxidative Capacity by Regulating Gpx1 Stability

T-Box20 Suppresses Oxidized Low-Density Lipoprotein-induced Human Vascular Endothelial Cell Injury by Upregulation of PPAR-γ

Transcriptome analysis reveals EBF1 ablation-induced injuries in cardiac system

PEX1 is a mediator of 1-adrenergic signaling attenuating doxorubicin-induced cardiotoxicity

Proximal telomeric decompaction due to telomere shortening drives FOXC1-dependent myocardial senescence

DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure

Cxcr4 Protects Cardiomyocytes From Beta-Adrenergic Stress-Induced Apoptosis

Differential Effects of and Mechanisms Underlying the Protection of Cardiomyocytes by Liver-X-receptor Subtypes Against High Glucose Stress-Induced Injury.

An Integrated Approach to Identify Critical Transcription Factors in the Protection Against Hydrogen Peroxide-Induced Oxidative Stress by Danhong Injection.

Targeting the Ferroptosis and Endoplasmic Reticulum Stress Signaling Pathways by CBX7 in Myocardial Ischemia/reperfusion Injury

SIRT1 Functions As an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy

Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice.

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure

Crosstalk between endothelial cells with a non-canonical EndoMT phenotype and cardiomyocytes/fibroblasts via IGFBP5 aggravates TAC-induced cardiac dysfunction

Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2

SIRT1-FOXOs signaling pathway: A potential target for attenuating cardiomyopathy